Universe Pharmaceuticals (UPC) Invested Capital (2020 - 2025)

Universe Pharmaceuticals has disclosed Invested Capital across 6 years of filings, most recently posting $58.2 billion for Q3 2025.

• Invested Capital for Q3 2025 came in at $58.2 billion, up 13.39% year-over-year; the trailing twelve-month figure through Sep 2025 was $58.2 billion (up 13.39% YoY), and the FY2025 annual result was $58.2 billion, up 13.39% from the prior year.
• Invested Capital came in at $58.2 billion for Q3 2025 at Universe Pharmaceuticals, up from $51.4 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $58.2 billion in Q3 2025 to a low of $32.3 million in Q1 2024.
• The 5-year median for Invested Capital is $14.0 billion (2022), against an average of $21.6 billion.
• Across the five-year window, Invested Capital sank 100.0% in 2021 and surged 75059.29% in 2022, its largest moves.
• Universe Pharmaceuticals' Invested Capital stood at $47.0 million in 2021, then soared by 75059.29% to $35.3 billion in 2022, then retreated by 20.82% to $28.0 billion in 2023, then surged by 83.59% to $51.4 billion in 2024, then grew by 13.39% to $58.2 billion in 2025.
• The last three Invested Capital figures came in at $58.2 billion (Q3 2025), $51.4 billion (Q3 2024), and $32.3 million (Q1 2024), per Business Quant data.